Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR tyrosine kinase inhibitors in non-small-cell lung carcinoma.
Kim HS, Sung JS, Yang SJ, Kwon NJ, Jin L, Kim ST, Park KH, Shin SW, Kim HK, Kang JH, Kim JO, Park JY, Choi JE, Yoon H, Park CK, Yang KS, Seo JS, Kim YH.
Kim HS, et al. Among authors: park jy, park kh, park ck.
PLoS One. 2013 Dec 20;8(12):e81975. doi: 10.1371/journal.pone.0081975. eCollection 2013.
PLoS One. 2013.
PMID: 24376508
Free PMC article.